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ABSTRACT The regulation of tumor suppressor genes by microRNAs (miRNAs) is of-
ten demonstrated as a one-miRNA-to-one-target relationship. However, given the
large number of miRNA sites within a 3= untranslated region (UTR), most targets
likely undergo miRNA cooperation or combinatorial action. Programmed cell death 4
(PDCD4), an important tumor suppressor, prevents neoplastic events and is com-
monly downregulated in cancer. This study investigates the relationship between
miRNA 21 (miR-21) and miR-499 in regulating PDCD4. This was explored using miRNA
overexpression, mutational analysis of the PDCD4 3= UTR to assess regulation at
each miRNA site, and 50% inhibitory concentration (IC50) calculations for combinato-
rial behavior. We demonstrate that the first miR-499 binding site within PDCD4 is
inactive, but the two remaining sites are both required for PDCD4 suppression. Ad-
ditionally, the binding of miR-21 to PDCD4 influenced miR-499 activity through an
increase in its silencing potency and stabilization of its mature form. Furthermore,
adjoining miRNA sites more than 35 nucleotides (nt) apart could potentially regulate
thousands of 3= UTRs, similar to that observed between miR-21 and miR-499. The
regulation of PDCD4 serves as a unique example of regulatory action by multiple
miRNAs. This relationship was predicted to occur on thousands of targets and may
represent a wider mode of miRNA regulation.
KEYWORDS cancer biology, cooperative regulation, gene silencing, head and neck
squamous cell carcinoma, HNSCC, microRNA, miRNA
Most human cancers represent an uncoupling of the gene expression pathwaysthat oversee cellular homeostasis. Mammalian cells express tumor suppressor
genes and provide a protective network to guard against transformation events. One
such tumor suppressor is programmed cell death 4 (PDCD4), which protects the cell
from early neoplastic changes (1) and is frequently downregulated in many cancers
(2–6). There exists a complicated network of direct and indirect mechanisms controlling
the expression of tumor suppressors such as PDCD4 (7). In recent years, microRNAs
(miRNAs), members of the noncoding RNA (ncRNA) family, have been shown to be
potent regulators of gene expression (8, 9). Small ncRNAs, including miRNAs, are
processed through a series of enzymatic steps to produce a 22-nucleotide (nt) miRNA
duplex (10). One strand of this duplex is loaded onto a silencing complex which directly
associates with target mRNAs to abrogate translation.
Typically, mammalian miRNAs bind to the 3= untranslated region (UTR) of a target
mRNA, with most studies describing a one-miRNA-to-one-target model. These results
have been largely driven by the prudent use of cell models to deliver one miRNA mimic
and measure the regulation of a single target gene. However, the 3= UTR usually
contains several hundred miRNA binding sites. Therefore, it stands to reason that
different miRNAs must partake in some manner of combinatorial regulation to perform
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gene regulation. However, the mechanism behind the coregulation of tumor suppres-
sor genes by multiple miRNAs is not fully understood.
In most situations, miRNA coregulation of a target can occur independently or in a
cooperative manner. Independent binding takes place when several different miRNAs
regulate the same target at different locations to confer a modest additive effect. In
contrast, cooperativity is driven by the binding of miRNAs at adjoining sites and results
in the amplification of regulatory potency. The difference between independent and
cooperative regulation largely relies upon the distance between miRNA binding sites.
Several biochemical studies have now determined that adjoining miRNA sites sepa-
rated by 13 to 40 nt display functional cooperativity (11–14). Therefore, any deviation
from this distance would likely shift the miRNA to an independent regulatory role.
This notion of miRNA cooperativity has been computationally explored on a
genome-wide scale. There is a statistical enrichment for adjoining miRNA sites (15 to
26 nt apart) in the human transcriptome (15). It has been further suggested that 17,259
human genes could be regulated in a cooperative fashion by 29,000 distinct miRNA
pairs (16). Importantly, an enrichment of adjoining binding sites is observed for those
miRNAs involved in regulating disease processes. The scope of this coregulation
underscores a widespread fundamental mechanism for miRNA-mediated silencing.
Despite the overwhelming predictive proof of the cooperative action of miRNAs, most
miRNA target evaluation studies focus only on the role of a single miRNA in the
regulation of a targeted mRNA.
There are approximately 100 miRNA binding sites on the 3= UTR of PDCD4, but only
a select few have been experimentally validated. The main contributor, miRNA 21
(miR-21), can act independently to regulate the expression of PDCD4 (17, 18). When
tested individually, it was also demonstrated that miR-182 (19), miR-183 (20), miR-320a
(21), miR-141 (22), and miR-499 (23, 24) regulate PDCD4, but it is not known if these
miRNAs display cooperativity. Since both miR-21 and miR-499 have been shown to
regulate the expression of PDCD4 in a diverse range of cancers, we asked whether
these miRNAs interact in their regulation of PDCD4. The binding sites for these two
miRNAs are highly conserved, with three miR-499 sites, at nt 17 to 23, nt 467 to 473, and
nt 533 to 539, and one miR-21 site, at nt 242 to 249, within the PDCD4 3= UTR.
Our study attempts to investigate the relationship between miR-21, miR-499, and the
regulation of PDCD4. We aim to determine whether these sites are dependent on each
other and how this affects the level of target regulation. Currently, there are limited studies
describing the action of multiple miRNAs on PDCD4. These findings contribute to a further
understanding of PDCD4 regulation but also expand our understanding of the possibility
of miRNAs working together to elicit target gene suppression.
RESULTS
PDCD4 expression is regulated by miR-21 and miR-499 in HNSCC. In a previous
study, we showed that several miRNAs were deregulated in head and neck squamous
cell carcinoma (HNSCC) clinical samples and that PDCD4 was regulated in a temporal
manner (23). Utilizing a cohort of oropharyngeal SCC clinical samples with adjacent
normal tissues (n  6), we confirmed that PDCD4 mRNA is downregulated in cancer
tissue (Fig. 1A) and that this regulation is orchestrated by miR-21-5p and miR-499a-5p
(Fig. 1B and C). Using The Cancer Genome Atlas (TCGA) database, we also observed an
increase in miR-21-5p levels and a decrease in PDCD4 transcripts across several other
cancers (Fig. 1D to F).
PDCD4 is regulated via one miR-21 and two miR-499 target sites. Although both
miRNAs regulate PDCD4, the individual contribution of their binding sites to the
repression of PDCD4 is unknown. The 3= UTR of PDCD4 harbors three miRNA sites for
miR-499a-5p and one predicted site for miR-21-5p, as predicted by TargetScan (25) (Fig.
2). To assess the individual contribution of these sites to PDCD4 silencing, we synthe-
tized part of the PDCD4 3= UTR that contains all the studied miRNA target sites. Mutant
PDCD4 3=-UTR sequences were developed by modifying the third, fifth, and seventh
nucleotides within the miRNA seed region. This was repeated for each studied miRNA
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FIG 1 The tumor suppressor gene PDCD4 is downregulated by miR-21 and miR-499. (A) Expression of PDCD4 mRNA in oral cancer tissue versus normal
adjacent tissue. The y axis represents the fold change of PDCD4 calculated using the 2CT method. The box plot represents the interquartile range with
the median value. Error bars are standard errors of the means (SEM) (n  6). *, P  0.05 (by Student’s t test). (B) Silencing of PDCD4 mRNA in HEK293
cells overexpressing miR-21 or miR-499 mimics. The y axis shows PDCD4 mRNA levels normalized to the value for control cells using the 2CT method.
Error bars are SEM (n  3). *, P  0.05; **, P  0.01; ***, P  0.005 (by one-way ANOVA with a Dunnett test). (C) PDCD4 protein levels in HEK293 cells
overexpressing miR-21 and miR-499 mimics. The reductions of PDCD4 protein levels were normalized with the tubulin loading control, and the values
for the transfected samples were then normalized to the control. Note that the final image is a composite of various gel lanes. This was required as miR-21
and miR-499 were separated by other samples in the Western blot, as indicated by the dotted lines. (D) Expression of miR-21 within TCGA for a selection
of normal and cancer tissues. (E) Expression of miR-499a-5p within TCGA for a selection of normal and cancer tissues. (F) Expression of PDCD4 within
TCGA for a selection of normal and cancer tissues. BRCA, breast invasive carcinoma; PRAD, prostate cancer; READ, rectal cancer; PAAD, pancreatic cancer;
LUNG, lung cancer; ns, not significant.
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site to produce the following four mutant sequences: M2 for the miR-21-5p binding site
and M1, M3, and M4 for the three miR-499a-5p binding sites, respectively. These 3=-UTR
mutants were then cloned into the dual-luciferase reporter system psiCHECK-2 and
transfected into UMSCC22B hypopharyngeal squamous cell carcinoma cells to ascertain
the contribution of each individual site to PDCD4 regulation.
To test if the cloned 3=-UTR segment could be targeted by miR-21 and miR-499, we
cotransfected the psi-WT reporter, containing the wild-type (WT) PDCD4 3= UTR,
in combination with miR-21 or miR-499 mimics. In UMSCC22B cells, we observed a
significant reduction in luciferase activity for cells containing these miRNAs and psi-WT
(Fig. 3A). The combination of the psi-M2 mutant and miR-21 resulted in a higher
luciferase activity than that of the WT control, indicating the abrogation of miR-21-
mediated PDCD4 suppression. However, gene regulation by miR-499 was still observed
(Fig. 3Aii).
To determine the contribution of the miR-499 sites, each PDCD4 3= UTR containing
a mutation for miR-499 was individually tested in combination with miR-21 and
miR-499 mimics. The cotransfection of miR-499 and psi-M1, containing a mutation in
the first miR-499 binding site, resulted in a luciferase activity similar to that of the
wild-type 3= UTR (Fig. 3Aiii). The cotransfection of miR-499 with either the psi-M3 or
psi-M4 plasmid resulted in an increase in luciferase activity compared to that of psi-WT
(Fig. 3Aiii). Given that one miR-499 site in each of these plasmids is not mutated, it was
expected that we would observe a decrease in luciferase activity similar to that of
the WT. However, this was not the case, which indicates that both binding sites of
miR-499a-5p are necessary for target repression. Therefore, given our results, we
suggest that both miR-499a-5p binding sites are required for PDCD4 suppression by
miR-499.
This series of transfections was repeated in two independent cell lines, HEK293 and
HeLa (Fig. 3B and C). The results from these cell lines demonstrate the same trend as
that for UMSCC22B cells, indicating that the underlying mechanism for PDCD4 sup-
pression by miR-21 and miR-499 is present in both cancerous and noncancerous cells.
However, the extent of the reduction in luciferase activity of the PDCD4 psiCHECK-2
FIG 2 Schematic of the PDCD4 3= UTR showing the miR-21 and miR-499 sites and their corresponding mutant
vectors. Each construct was synthesized using Invitrogen GeneArt and then subcloned into psiCHECK-2. The
corresponding mutant vectors were psi-WT for the wild-type 3= UTR, psi-M1 for mutation of the first miR-499 site,
psi-M2 for mutation of the miR-21 site, psi-M3 for mutation of the second miR-499 site, and psi-M4 for mutation
of the last miR-499 site. The red nucleotides represent the mutations introduced at the miRNA binding site.
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plasmids is different across the tested cell lines, indicating that the extent of PDCD4
suppression may be cell line specific. From these observations, we concluded that both
miR-21 and miR-499 can independently recognize the 3= UTR of PDCD4 and that the
action of miR-499 requires both the second and third miR-499 sites to be intact.
Effect of miR-21 on efficiency of miR-499 binding of PDCD4. Although the series
of luciferase assays demonstrated that both miR-21 and miR-499 regulate PDCD4, the
question remains as to whether its silencing efficiency is altered depending on miRNA
abundance and binding site availability. To answer this, we measured the 50% inhib-
itory concentration (IC50) (concentration of miRNA needed to achieve half-maximal
silencing of the tumor suppressor PDCD4) of miR-499 by cotransfecting it at increasing
concentrations, together with psi-WT or the miR-21 mutant plasmid (psi-M2). The
absence of an intact miR-21 binding site increased the IC50 by 10-fold compared to that
of the wild type. This indicates that more miR-499 is required to suppress the PDCD4
3= UTR in the absence of the miR-21 site (Fig. 4A).
FIG 3 PDCD4 silencing by miR-21 and miR-499a-5p in HEK293 (A), UMSCC22B (B), and HeLa (C) cell lines. Cells
were cotransfected with 30 pmol of control (i), miR-21 (ii), and miR-499 (iii) mimics in combination with the
psi-WT or mutant vectors. Each color indicates a different psi-CHECK vector. The silencing contribution for each
miRNA was assessed using relative light units (luciferase activity) and normalized to the value for control cells.
Error bars represent SEM (n  3). *, P  0.05; **, P  0.01; ***, P  0.005 (by one-way ANOVA with a Dunnett test).
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Next, we asked if miR-21 levels directly influence the efficiency of miR-499 in
targeting PDCD4. This is particularly relevant in HNSCC cells, as miR-21 levels are higher
than those of miR-499 (23). To test this, cells were cotransfected with psi-WT in
combination with either 30 pmol of miR-21 or let-7 (nontargeting control miRNA
mimic). To these same cells, miR-499 was delivered at increasing concentrations. Our
results indicated a 21-fold drop in the IC50 for miR-499 when miR-21 is expressed at
high levels (Fig. 4B). This means that less miR-499 is required to achieve PDCD4
suppression when miR-21 is present at high levels. This therefore could result in a
greater suppression of PDCD4 through the action of these two miRNAs.
miR-21 increases miR-499 levels. While performing optimizations for the delivery
of these miRNAs, we observed that transfection of the miR-21 mimic resulted in an
increase in not only the level of miR-21 expression but also the level of miR-499 (Fig.
5A and B). To determine whether miR-21 specifically affected miR-499 levels, we
measured the expression level of the control miRNA, miR-17, in the same transfection
and observed no change (Fig. 5C). Interestingly, when we transfected miR-21 antisense
(AS) to deplete miR-21 levels, there was no change in miR-499 expression (Fig. 5D and
E). Although miR-21 increases miR-499 levels, this relationship was not reciprocated, as
psi-M2 IC50 : 0.176+/- 0.093
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FIG 4 miR-21 increases the silencing potency of miR-499. HEK293 cells were transfected with the miR-499
mimic (concentration range of between 0.0012 and 12 pmol) in combination with either psi-WT or psi-M2. The
cells were then harvested at 24 h, and luciferase activity was measured. (A) The silencing potency of miR-499
in cells expressing the miR-21 mutant (psi-M2) and the wild-type (psi-WT) vectors. The calculated IC50 for cells
harboring the mutant miR-21 vector is 10-fold higher than that for control cells. (B) miR-21 levels can affect
miR-499 potency. Cells were transfected with either 30 pmol of the miR-21 or control mimic in combination
with the wild-type vector. The addition of miR-21 reduces the IC50 required for miR-499 silencing compared
to the control mimic. Pp, Photinus pyralis; Rr, Renilla reniformis.
Ajuyah et al. Molecular and Cellular Biology
September 2019 Volume 39 Issue 18 e00086-19 mcb.asm.org 6
 on A



























cells overexpressing miR-499 did not affect the mature levels of miR-21 (Fig. 5F). This
suggests that the level of miR-499 is increased only under high-miR-21 conditions and
that this relationship is unidirectional.
miR-21 stabilizes mature miR-499 levels. To test if miR-21 increased the tran-
scription of miR-499, we quantified the level of primary miR-499 (pri-miR-499) in
HEK293 cells that were transfected with either a control, miR-21, or miR-499 mimic. Our
data showed no significant changes in the expression levels of pri-miR-499 with miR-21
overexpression (Fig. 6A). Therefore, it was postulated that miR-21 overexpression may
elevate the mature levels of miR-499 by affecting its turnover rate. To test this, HEK293





FIG 5 miR-21 increases the expression of miR-499. (A) Expression of miR-21 in cells overexpressing the
miRNA mimic. HEK293 cells were transfected with 1, 10, and 30 pmol control or miR-21 mimics. The
expression of miR-21 was then normalized to the value for RNU6B, and the resulting fold change is
expressed relative to the value for control cells at their specific concentrations. (B) Elevated expression
of miR-499 in HEK293 cells transfected with 1, 10, and 30 pmol of the miR-21 mimic. The fold change is
expressed relative to the value for control cells at each concentration. (C) Expression of miR-17 is not
increased in HEK293 cells overexpressing 30 pmol of the miR-21 mimic. (D) Expression of miR-21 in cells
overexpressing the miR-21 mimic or miR-21 antisense (AS). (E) Expression of miR-499 in HEK293 cells
transfected with miR-21 AS, delivered at three different concentrations. The fold change in the miR-499
level was normalized to the value for control AS cells at each concentration. (F) Cells overexpressing
miR-499 at either 30 or 10 pmol do not show an increase in miR-21 levels. The fold changes of both
miRNAs are presented relative to the control (all error bars are SEM [n  3]).
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actinomycin D (actD), to inhibit de novo transcription, or the vehicle control dimethyl
sulfoxide (DMSO). To confirm that actD was active in inhibiting transcription, we
measured c-myc, which has an RNA half-life of approximately 30 min (26). There is a
clear reduction of c-myc RNA 3 h after actD treatment, indicating that transcriptional
activity was effectively inhibited (Fig. 6B). The primary levels of both miR-21 and
FIG 6 miR-21 stabilizes mature miR-499 levels. (A) pri-miR-499 levels in cells overexpressing either miR-499
or miR-21. The y axis represents the fold change of the primary miRNA level, normalized to the value for B2M
and then to the value for control cells using the 2CT method. (B) Fold changes in c-myc mRNA levels in
HEK293 cells over 24 h in cells overexpressing miR-21 or control mimics in combination with actD treatment.
The expression of c-myc was normalized to the value for B2M, and the resulting fold change on the y axis
was normalized to the value for the control or miR-21 at 0 h. (C) Reduction of the miR-21 primary transcript
measured over 24 h in cells overexpressing the miR-21 mimic with actD treatment. (D) Primary miR-499
transcript levels were stabilized in cells overexpressing the mature miR-21 mimic. Fold changes for the
primary miRNA transcripts were calculated as described above for c-myc. (E) Change in miR-21 levels in
actD-treated HEK293 cells overexpressing the miR-21 mimic. (F) Increased expression levels of mature
miR-499 over 24 h in actD-treated cells overexpressing miR-21. (G) Expression of Let-7g in actD-treated cells
overexpressing miR-21. The mature levels of Let-7g were degraded over the 24-h period. Error bars are SEM
(n  3). *, P  0.05 (by a two-sided unpaired t test).
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miR-499 were measured to test our hypothesis that miR-21 affects miR-499 turnover.
We observed a rapid decrease in both primary transcripts with miR-21 transfection,
indicating that miR-21 and miR-499 transcription was hindered (Fig. 6C and D). As
expected, the mature level of miR-21 was elevated due to the transfection of the miR-21
mimic (Fig. 6E). Interestingly, mature miR-499 levels were markedly increased at 24 h,
despite transcriptional inhibition by actD (Fig. 6F). To determine whether miR-21
explicitly influences miR-499 processing and stability, we measured the levels of let-7g
in these samples. We did not observe any increase in let-7g levels in miR-21-transfected
cells, supporting the specific nature of the relationship between miR-21 and miR-499
(Fig. 6G).
The expanding regulatory network of miR-21 and miR-499. Given that miR-21
and miR-499 participate in the coregulation of PDCD4, we postulated that this may be
representative of a wider phenomenon in miRNA-mediated silencing. To this end, we
analyzed the target prediction results from TargetScan (25) and miRanda (27) for
miR-21 and miR-499 and limited the set of predicted genes to those targeted by both
miRNAs (Table 1). These targets were then assessed for Ago2 footprints on the 3= UTR
using photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipita-
tion (PAR-CLIP) data (28). Interestingly, the presence of a CLIP-supported miR-21 site on
these targets increased the probability of the presence of a downstream predicted CLIP
miR-499 binding site by 20%, compared to no CLIP support for the miR-21 binding site.
This analysis was expanded by focusing on the common predicted targets of the two
miRNAs that contain only one predicted binding site for miR-21 and more than one
predicted binding site for miR-499. The probability of having at least one predicted
miR-499 site supported by CLIP data increased to 38%. Therefore, a single miR-21
binding site increases the probability of downstream miR-499 binding sites within the
same target gene.
Next, we put forward the notion that miR-21 may promote cotargeting with other
downstream miRNA sites besides miR-499. To test this, we randomly selected 10 other
miRNAs from a shuffled pool of the miRNAs present in miRBase version 20 (29). The
above-described analysis was applied to these randomly selected miRNAs, using the
prerequisite of containing a single miR-21 upstream site. A list of overlapping genes
was generated for miR-21 and each of the randomly selected miRNAs. We then












Experimental evidence of interaction
miR-21 miR-499
SOX6 (NM_001145811) 5 1 170, 305, 15, 287, 290 NA Luciferase
PURB (NM_033224) 1 3 1,726, 3,430, 750 Microarray NA





JHDM1D (NM_030647) 1 2 4,229, 7 NA NA
SECISBP2L (NM_001193489) 1 2 1,080, 1,428 NA NA
PAIP2B (NM_020459) 1 2 729, 52 NA NA





SCRN1 (NM_001145513) 1 1 3,334 Microarray NA
ARHGAP32 (NM_001142685) 1 1 49 NA NA
KLHDC5 (NM_020782) 1 1 2,175 NA NA
RAB22A (NM_020673) 1 1 1,650 NA NA
MEIS1 (NM_002398) 2 0 461 Microarray NA
LRP6 (NM_002336) 1 1 576 NA NA
FOXP2 (NM_001172766) 1 1 26 NA NA
STRN (NM_003162) 1 1 1,853 NA NA
aEach transcript in the table represents at least one conserved binding site predicted for miR-21-5p and at least two binding sites predicted for miR-499a-5p. SOX6,
SRY box 6; NA, not applicable.
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inspected if the presence of a single CLIP-supported predicted binding site for miR-21
increased the probability of having more than one CLIP-supported predicted binding
site for the randomly chosen miRNAs. For all 10 selected miRNAs, we observed a
significant increase (P  0.0001 by Bernard’s exact test) in the probability of having at
least one CLIP-supported predicted binding site (Table 2). In other words, there is a
strong statistical likelihood that the presence of a single upstream miR-21 binding site
will result in an adjoining downstream miRNA binding site.
Finally, as the two miR-499 sites were separated by 66 nt and were both required
for PDCD4 suppression, we investigated if there was an overrepresentation of other
adjoining miRNA sites separated by similar distances. The subsequent analysis was
restricted to 163 conserved miRNAs with the distance between adjoining pairs set
between 35 and 100 nt. This threshold was set as previous reports have stated that
distances of less than 35 nt have a cooperative effect (11–14). In total, there were 96,000
3= UTRs with adjoining miRNA binding sites separated by 35 to 100 nt. In comparison,
over 165,000 3= UTRs were targeted by adjoining miRNAs less than 35 nt apart (Fig. 7A).
This suggests that adjoining miRNA pairs separated by 35 to 100 nt may have a wider
role in gene regulation. We then sought to identify which adjoining miRNA pairs were
the most prominent in the 35- to 100-nt and 35-nt data sets. The analysis of the 35-
to 100-nt data set indicated that miR-200c, miR-200b, and miR-429 adjoining pairs were
overrepresented on more than 2,300 3= UTRs. In contrast, miR-16, miR-497, miR-195,
miR-15a, miR-15b, and miR-424 pairs were found on 16,000 3= UTRs in the 35-nt data
set (Fig. 7B). This suggests that the miRNAs in adjoining pairs separated by larger
distances are distinct from those in adjoining pairs separated by 35 nt or less.
DISCUSSION
PDCD4 is a translational inhibitor which is often upregulated during apoptosis (30).
However, in a disease setting such as cancer, PDCD4 is frequently downregulated, and
its expression has been correlated with disease progression in various malignancies (2,
31, 32). We and others have further shown that the PDCD4 protein is deregulated in
oral tumors and is posttranscriptionally regulated by miR-21 and miR-499 (18, 23). On
this basis, we investigated whether there was a relationship between these two miRNAs
in their control of PDCD4.
To understand the individual involvement of miR-21 and miR-499 in the silencing of
PDCD4, we mutated the miR-21 and three miR-499 binding sites within its 3= UTR and
tested their contribution using a series of luciferase assays. As expected, mutations at













SOX6 (NM_001145811) * *
PURB (NM_033224) 3 *
PDCD4 (NM_001199492) 12 1
JHDM1D (NM_030647) 3 3
SECISBP2L (NM_001193489) * 1
PAIP2B (NM_020459) * *
SOX5 (NM_006940) 9 2
SCRN1 (NM_001145513) 1 6
ARHGAP32 (NM_001142685) 4 *
KLHDC5 (NM_020782) 8 2
RAB22A (NM_020673) 1 3
MEIS1 (NM_002398) 9 1
LRP6 (NM_002336) 10 0
FOXP2 (NM_001172766) 9 *
STRN (NM_003162) * *
a* indicates the absence of cross-linking immunoprecipitation sequencing (CLIP-Seq) evidence of the
interaction of the corresponding miRNA and its predicted target.
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the miR-21 seed region abolished miR-21-mediated silencing, which is congruent with
other studies (33). Our results indicate that the first miR-499-5p binding site does not
contribute to PDCD4 suppression, likely due to the impedance of ribosomes within the
first 15 nt of the 3= UTR (34).
To our surprise, the second and third miR-499 binding sites appear to be dependent.
In the series of luciferase assays across several cell lines, the mutation of one of these
sites abolished PDCD4 silencing, despite the presence of a nonmutated site. This
finding is novel and is distinct from the cooperative action observed for adjoining
miRNA sites. These two miR-499 sites are 66 nt apart and are therefore beyond the 13-
to 35-nt distance that defines miRNA site cooperativity (11–13). It has been reported
that miRNA-loaded Ago2 scans the target RNA by lateral diffusion and binds to
complementary regions matching the seed (35). It has also been demonstrated that
neighboring miRNA binding sites synergistically increase the dwell time of Ago2 on
target RNAs. Perhaps both miR-499 sites are needed to establish the required dwell
time on PDCD4 for Ago2-bound miR-499-mediated silencing.
FIG 7 Adjoining miRNA sites separated by 35 to 100 nt are overrepresented on target 3=UTRs. (A) Distribution
plot showing the number of potential targets for 167 adjoining miRNA sites separated by 35 to 100 nt or 0
to 35 nt or with no distance constraints (Any). (B) Bubble chart showing the specific miRNAs that were
overrepresented as adjoining pairs separated by either 35 to 100 nt (orange) or 0 to 35 nt (blue). The larger
bubble size indicates a greater number of targets with adjoining sites for the specific miRNA.
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Our results also indicate that the efficiency of miR-499 targeting is increased by the
presence of both an intact miR-21 binding site and high levels of miR-21. This may be
explained by the thermodynamic properties of their respective binding sites. Within the
RNA secondary structure, the miR-21 binding site has a lower free energy, ΔG, of 2.69
and thus is the most energy-efficient site for the access of the RNA-induced silencing
complex (RISC). The first miR-499 binding site has the highest free energy (ΔG of 6.04)
and is the least accessible to the RISC, as discussed above. The ΔG values of the last two
binding miR-499 sites are 1.57 and 1.58, respectively (23). Based on the thermody-
namic properties of these binding sites, we reasoned that in a cellular environment with
high miR-21 levels, the loaded miR-21–Ago2 complex first binds to the more accessible
miR-21 site within PDCD4. This initial event may induce conformational changes in the
tertiary structure of the PDCD4 3= UTR to increase the accessibility of the distal sites,
allowing for the efficient binding of Ago2-bound miR-499. This may provide an
explanation as to how miR-21 increases miR-499 binding efficiency, as observed in our
results.
The steady-state levels for most miRNAs require a balance between transcription
and degradation (36); our results indicate that miR-21 stabilizes mature miR-499 but
does not promote the synthesis of new primary miR-499. This example of miRNA-
mediated miRNA regulation is in contrast with those studies showing a direct binding
between two miRNAs (37) or an influence on miRNA abundance through the biogen-
esis pathway (38). In melanoma, lung, and breast cancer cell lines, it was demonstrated
that miR-107 could directly interact with Let-7 to promote its degradation (37). Addi-
tionally, miR-709 has been shown to bind to a 19-nt region within the primary transcript
of miR-15a/16 to abrogate downstream maturation (39). More recently, miR-21 was
shown in colon cancer stem cells to reduce the expression of miR-145 (40). These
examples all highlight a negative regulatory role for miRNAs in the control of other
miRNAs. However, our study demonstrated a positive regulatory role for miR-21 in the
modulation of miR-499.
The key question that arose during our investigations was in regard to the stabili-
zation of mature miR-499, for which we suggest two possible explanations. The first is
that these two miRNAs can bind to each other to form hybrid duplexes (41). Using
miRWalk 2.0 to examine possible hybridization patterns between different miRNAs, we
observed that the only miR-21-5p binding partner, from a pool of 1,880 miRNAs, was
miR-499-3p. Thus, it may be that the 5p arm of miR-21 interacts with the 3p arm of
miR-499 to increase the levels of miR-499-5p. Another scenario is that the overexpres-
sion of miR-21 affects the target pool of miR-499. This was first reported in Caenorhab-
ditis elegans (42), whereby the overexpression of an artificial target bearing three let-7
binding sites increased let-7 levels. Conversely, a reduction in target availability reduces
mature miRNA levels (42). Another recent study using mammalian cells found that
decay rates for miRNAs can be influenced by target abundance (43). This is speculation,
but perhaps the overexpression of miR-21 creates a larger pool of miR-499 targets,
allowing for the stabilization of miR-499 levels (44).
Given that miR-21 is one the highest-expressing miRNAs in most cancers and
diseased tissue, we suggest that miR-499 is not the only recipient of this positive
regulation. Our computational results indicate that the presence of a miR-21 binding
site increased the likelihood of adjoining downstream miRNA binding sites. Therefore,
this mode of regulation is not restricted to miR-499 but may represent an additional
layer of miRNA control. This bioinformatic evidence suggests a far greater regulatory
potential for miR-21 in conjunction with adjoining miRNA pairs and the wider influence
of these interactions on the microRNAome.
To conclude, we show that PDCD4, a tumor suppressor gene suppressed in many
cancers, is regulated through a relationship between miR-21 and miR-499. We dem-
onstrate that the first miR-499 binding site on PDCD4 is not active, but the remaining
two miR-499 sites are both needed to elicit miR-499-mediated silencing. Additionally,
the binding of miR-21 amplified the silencing potency of miR-499 by 10-fold, and
miR-21 appears to stabilize the levels of mature miR-499. As miR-21 is a prominent
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oncomiR (45, 46), we show that it may have an additional role in increasing the binding
efficiency of lowly expressed miRNAs. Also, the presence of a miR-21 site increases the
probability of downstream adjoining miRNA sites, indicating a suggested role for
miR-21 cooperation with other miRNAs. Our results highlight the complexity of miRNA
regulation far beyond the simplistic model of one miRNA to one target gene. The
regulation of PDCD4 by miR-21 and miR-499 typifies the complex partnerships that can
exist between regulatory miRNAs when targeting mammalian tumor suppressor genes.
MATERIALS AND METHODS
Patient samples and cell lines. Head and neck tumor tissue and microscopically matched normal
adjacent tissue (2 cm outside the surgical margin) (n  6) were used for quantitative real-time PCR
(qRT-PCR) analysis. Usage of these patient samples was approved by the Research Ethics Committee at
Royal Prince Alfred Hospital, Sydney, Australia (protocols X05-269 and X05-270). This protocol covered
consent and collection of material excess to diagnostic requirements for research purposes only.
TCGA analysis. Gene and miRNA expression data, and associated clinical data for various cancers
from The Cancer Genome Atlas (TCGA), were downloaded from the UCSC Xena Functional Genomics
Explorer (https://xenabrowser.net). The data were filtered to separate the expression levels for primary
tumor and matched normal samples. miR-21, miR-499, and PDCD4 expression was plotted and analyzed
using GraphPad Prism 8.0.1.
Cell culture. HEK293, HeLa, and UMSCC22B cell lines (Invitrogen) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) (4.5 g/liter glucose, 4 mM L-glutamine, and 110 mg/liter sodium pyruvate) (Life
Technologies), supplemented with 10% fetal bovine serum (Gibco) at 37°C with 5% CO2.
Isolation of RNA from fresh tissue or cultured cells. Approximately 100 mg of fresh frozen tissue
was diced, homogenized, and then rinsed with 1 ml of TRIzol reagent (Invitrogen). For cell lines, 1 ml of
TRIzol was added to the cell pellet, with further disruption through a 21-gauge needle. Total RNA was
then extracted using isopropanol precipitation and quantified using a NanoDrop ND1000 instrument
(Thermo Fisher Scientific). Samples with a 260/280-nm absorbance ratio in the range of 1.71 to 2.1 were
used for downstream studies.
DNA and RNA transfection. Lipofectamine 2000 was used to transfect plasmid DNA (50 ng) and miRNA
mimics (Ambion) into HEK293, UMSCC22B, and HeLa cells. According to the manufacturer’s instructions,
4  104 cells were seeded into each well of a 24-well plate prior to transfection. DNA was diluted with
Opti-MEM (Life Technologies), while 1.5 l Lipofectamine 2000 was diluted with Opti-MEM and incubated for
5 min before both diluents were combined. The mixture was incubated for 20 min at room temperature and
then added to each well of a 24-well plate. After transfection, cells were harvested, and luciferase activity was
measured using the dual-luciferase reporter assay system (Promega).
Alternatively, we also utilized Lipofectamine RNAiMAX (Invitrogen) to deliver miR-21, miR-499, a
scrambled precursor, and let-7a (negative control) into HEK293 cells. Briefly, 1  105 cells were seeded
into wells of a 6-well plate. miRNA mimics at various concentrations (1 pmol, 10 pmol, and 30 pmol) and
Lipofectamine RNAiMAX were diluted with Opti-MEM separately for 5 min and then incubated together
for 20 min before addition to cells. Total RNA was collected 24 h after transfection and used for
downstream molecular analysis.
Quantitative real-time PCR. miRNA and mRNA expression levels were measured using the Applied
Biosystems StepOne real-time PCR systems machine and TaqMan assays (Life Technologies). RNU6B or U6
small RNA was used for the normalization of miRNA expression, while glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) or actin acted as the reference/calibrator control. The fold expression of these
RNAs was calculated using the 2CT method (47). For fold change values of between 0 and 1, the
negative inverse (1 divided by the calculated fold change) was calculated to better visualize and
interpret the results.
Cloning of wild-type PDCD4 and mutant 3= UTRs into luciferase reporter vectors. The wild-type
and mutant 3= UTRs were synthesized by GeneArt (Invitrogen) and cloned into the multiple-cloning site
(MCS) of the psiCHECK-2 vector (Promega) using the restriction enzymes EagI and NotI. The expression
of the Renilla signal was used to determine the regulation of the PDCD4 3= UTR by miRNA mimics. The
firefly luciferase gene in psiCHECK-2 was used for normalization. The psi-M2 construct contained the
3=-UTR PDCD4 sequence with single nucleotide mutations at the 3rd, 5th, and 7th nucleotides at
the miR-21 seed sequence (nt 242 to 249). This same principle was applied to the psi-M1 construct with
mutations at the first miR-499 seed sequence (nt 17 to 23), psi-M3 with mutations at the second miR-499
seed sequence (nt 467 to 473), and psi-M4 with mutations at the third miR-499 seed sequence (nt 533
to 539).
Measurement of protein expression by Western blotting. Transfected cells were harvested and
lysed with CellLytic M cell lysis reagent (Sigma-Aldrich) supplemented with 0.1% serine protease inhibitor
(Sigma-Aldrich). The protein concentration was determined using the Bradford assay (Bio-Rad) and the
Qubit 2.0 fluorometer (Life Technologies), with bovine serum albumin (BSA) acting as a standard. Twenty
micrograms of protein was loaded onto a precast NuPAGE (4 to 12%) Bis-Tris gel (Invitrogen) in NuPAGE
morpholineethanesulfonic acid (MES)-SDS running buffer (50 mM MES, 50 mM Tris base, 0.1% SDS, 1 mM
EDTA). After electrophoresis, the proteins were transferred onto a polyvinylidene difluoride (PVDF)
membrane (Pierce) using NuPAGE transfer buffer (25 mM Bicine, 25 mM Bis-Tris, 1 mM EDTA). The
membrane was incubated with PDCD4 (1:5,000) or tubulin (1:1,000), followed by conjugation with a
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secondary antibody containing horseradish peroxidase (HRP). Chemiluminescence with the ECL plus
reagent (GE Healthcare Life Sciences) was used to visualize the specific protein bands.
Measurement of miRNA inhibition by luciferase assays. The Dual-Luciferase reporter assay system
(Promega) was used to measure the luciferase activity of cells cotransfected with wild-type and mutant
PDCD4 3=-UTR vectors in combination with miRNA mimics. Firefly and luciferase activities were measured
24 h after transfection. The cells were washed with a phosphate-buffered saline (PBS) solution and lysed
with 100 l of passive lysis buffer (Promega) for 15 min at room temperature. The contents of each well
were then freeze-thawed to complete lysis, and 20 l of the lysate was added to individual wells of an
opaque 96-well plate (PerkinElmer). This was followed by the addition of 100 l of luciferase assay
reagent II (LARII) (Promega). The Tecan Infinite 200 Pro spectrophotometer was then used to measure
firefly activity. After this measurement, 100 l of Stop & Glo reagent (Promega) was added to each well,
and Renilla activity was measured. For each luminescence reading, there was a 2-s premeasurement
delay, followed by a 10-s measurement period. Analyses of all samples were performed in triplicates, and
luciferase activity was expressed as a Renilla/firefly ratio to normalize for cell number and transfection
efficiency. Each transfection condition was calculated as a ratio of the control let-7a luciferase activity.
This calculation was separately applied to each of the different mutant transfection conditions.
Cotransfection of reporter mutant vectors at various miRNA mimic concentrations. To evaluate
the contribution of these miRNA sites to silencing efficacy, we cotransfected miRNA mimics at various
concentrations (0.0012, 0.012, 0.06, 0.12, 1.2, and 12 pmol) in combination with the WT or mutant vectors.
These miR-21 or miR-499 mimics were mixed with 50 ng the 3=-UTR PDCD4 vector and transfected into
4  104 HEK293 cells in a 12-well plate. The cells were then harvested at 24 h, and luciferase activity was
measured. The IC50 was calculated using the Hill equation (48), and propagated error and titration graphs
were created with the Igor Pro Carbon program.
Quantification of miRNA stability using actinomycin D. A total of 4  105 cells were seeded into a
6-well plate. After 24 h, cells were transfected with control miRNA and miR-21 mimics at 30 pmol and
incubated for 3 h before the addition of actinomycin D (actD) (5 g/ml). After the addition of actD, cells were
lysed with RNAzol at the 0-, 1-, 3-, 12-, and 24-h time points, and RNA was isolated for subsequent quantitative
PCRs (qPCRs) measuring miRNA stability. The turnover rate for each miRNA was calculated using the 2CT
method to determine the fold change of the miRNA with overexpression of the control mimic and miR-21 in
cells. The fold change of the miRNA at each time point was then normalized to the value at time zero.
Bioinformatics analysis. Predicted targets of miR-21, miR-499, and randomly selected miRNAs used
in this study were downloaded from TargetScan version 7.0 and miRanda, August 2010 release. The
random selection of miRNAs from the shuffled pool was based on the condition that no selected miRNA
would share the same seed region as miR-21. To achieve this, all miRNAs with the same seed region as
miR-21 were removed from the miRNA pool. Both miRanda and TargetScan were set at a low prediction
cutoff to obtain the maximum number of target predictions for each miRNA. The preprocessed PAR-CLIP
data set of genome-wide Ago2 interactions was downloaded from StarBase v2.0. Locus site coordinate
mapping of the predicted binding sites of miRNAs and the Ago2 footprints was performed in Python.
Predicted binding sites for miRNAs with Ago2 interaction support were regarded as those with an
overlapping length of at least 1 nucleotide and a colocalized Ago2 footprint on the same loci.
Alternatively, miRNA binding sites without Ago2 interaction support were classified as those devoid of
an Ago2 CLIP site on the same loci.
Statistical analysis. One-way analysis of variance (ANOVA) with Dunnett’s multiple-comparison test
was used to analyze the series of luciferase assays. Fold change values were analyzed using unpaired
two-tailed Student’s t test. All P values of 0.05 were considered statistically significant. All statistical
calculations were performed in Prism version 8 (GraphPad).
REFERENCES
1. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H,
Matsuhashi S, Colburn NH. 1999. Differentially expressed protein Pdcd4
inhibits tumor promoter-induced neoplastic transformation. Proc Natl
Acad Sci U S A 96:14037–14042. https://doi.org/10.1073/pnas.96.24
.14037.
2. Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki
I, Petersen I. 2003. Loss of PDCD4 expression in human lung cancer
correlates with tumour progression and prognosis. J Pathol 200:
640 – 646. https://doi.org/10.1002/path.1378.
3. Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O. 2007.
Alterations in the expression of PDCD4 in ductal carcinoma of the breast.
Oncol Rep 18:1387–1393.
4. Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post
S, Jansen A, Colburn NH, Allgayer H. 2007. Loss of programmed cell
death 4 expression marks adenoma-carcinoma transition, correlates in-
versely with phosphorylated protein kinase B, and is an independent
prognostic factor in resected colorectal cancer. Cancer 110:1697–1707.
https://doi.org/10.1002/cncr.22983.
5. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi
H, Yamamoto K, Matsuhashi S. 2006. Involvement of programmed cell
death 4 in transforming growth factor-beta1-induced apoptosis in hu-
man hepatocellular carcinoma. Oncogene 25:6101– 6112. https://doi
.org/10.1038/sj.onc.1209634.
6. Carinci F, Lo Muzio L, Piattelli A, Rubini C, Chiesa F, Ionna F, Palmieri A,
Maiorano E, Pastore A, Laino G, Dolci M, Pezzetti F. 2005. Potential
markers of tongue tumor progression selected by cDNA microarray.
Int J Immunopathol Pharmacol 18:513–524. https://doi.org/10.1177/
039463200501800311.
7. Lankat-Buttgereit B, Göke R. 2009. The tumour suppressor Pdcd4: recent
advances in the elucidation of function and regulation. Biol Cell 101:
309 –317. https://doi.org/10.1042/BC20080191.
8. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian
mRNAs are conserved targets of microRNAs. Genome Res 19:92–105.
https://doi.org/10.1101/gr.082701.108.
9. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky
N. 2008. Widespread changes in protein synthesis induced by microR-
NAs. Nature 455:58 – 63. https://doi.org/10.1038/nature07228.
10. Tran N, Hutvagner G. 2013. Biogenesis and the regulation of the matu-
ration of miRNAs. Essays Biochem 54:17–28. https://doi.org/10.1042/
bse0540017.
11. Sætrom P, Heale BSE, Snøve O, Jr, Aagaard L, Alluin J, Rossi JJ. 2007.
Distance constraints between microRNA target sites dictate efficacy and
Ajuyah et al. Molecular and Cellular Biology
September 2019 Volume 39 Issue 18 e00086-19 mcb.asm.org 14
 on A



























cooperativity. Nucleic Acids Res 35:2333–2342. https://doi.org/10.1093/
nar/gkm133.
12. Broderick JA, Salomon WE, Ryder SP, Aronin N, Zamore PD. 2011.
Argonaute protein identity and pairing geometry determine coopera-
tivity in mammalian RNA silencing. RNA 17:1858 –1869. https://doi.org/
10.1261/rna.2778911.
13. Doench JG, Petersen CP, Sharp PA. 2003. siRNAs can function as miRNAs.
Genes Dev 17:438 – 442. https://doi.org/10.1101/gad.1064703.
14. Koscianska E, Witkos TM, Kozlowska E, Wojciechowska M, Krzyzosiak WJ.
2015. Cooperation meets competition in microRNA-mediated DMPK
transcript regulation. Nucleic Acids Res 43:9500 –9518. https://doi.org/
10.1093/nar/gkv849.
15. Rinck A, Preusse M, Laggerbauer B, Lickert H, Engelhardt S, Theis FJ.
2013. The human transcriptome is enriched for miRNA-binding sites
located in cooperativity-permitting distance. RNA Biol 10:1125–1135.
https://doi.org/10.4161/rna.24955.
16. Schmitz U, Lai X, Winter F, Wolkenhauer O, Vera J, Gupta SK. 2014.
Cooperative gene regulation by microRNA pairs and their identification
using a computational workflow. Nucleic Acids Res 42:7539 –7552.
https://doi.org/10.1093/nar/gku465.
17. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S,
Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally down-
regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation
and metastasis in colorectal cancer. Oncogene 27:2128 –2136. https://
doi.org/10.1038/sj.onc.1210856.
18. Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M,
Sukhai MA, Perez-Ordonez B, Grenman R, Gilbert RW, Gullane PJ, Irish JC,
Kamel-Reid S. 2010. Programmed cell death 4 loss increases tumor cell
invasion and is regulated by miR-21 in oral squamous cell carcinoma.
Mol Cancer 9:238. https://doi.org/10.1186/1476-4598-9-238.
19. Wang YQ, Guo RD, Guo RM, Sheng W, Yin LR. 2013. MicroRNA-182
promotes cell growth, invasion, and chemoresistance by targeting pro-
grammed cell death 4 (PDCD4) in human ovarian carcinomas. J Cell
Biochem 114:1464 –1473. https://doi.org/10.1002/jcb.24488.
20. Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J, Qin Y, Sun Z, Zheng X. 2010. miR-183
inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 ex-
pression in human hepatocellular carcinoma cells. BMC Cancer 10:354.
https://doi.org/10.1186/1471-2407-10-354.
21. Wang W, Zhao L, Wei X, Wang L, Liu S, Yang Y, Wang F, Sun G, Zhang J,
Ma Y, Zhao Y, Yu J. 2016. MicroRNA-320a promotes 5-FU resistance in
human pancreatic cancer cells. Sci Rep 6:27641. https://doi.org/10.1038/
srep27641.
22. Fu WF, Chen WB, Dai L, Yang GP, Jiang ZY, Pan L, Zhao J, Chen G. 2016.
Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung
cancer cells via upregulation of programmed cell death protein 4. Eur
Rev Med Pharmacol Sci 20:2565–2572.
23. Zhang X, Gee H, Rose B, Lee CS, Clark J, Elliott M, Gamble JR, Cairns MJ,
Harris A, Khoury S, Tran N. 2016. Regulation of the tumour suppressor
PDCD4 by miR-499 and miR-21 in oropharyngeal cancers. BMC Cancer
16:86. https://doi.org/10.1186/s12885-016-2109-4.
24. Liu X, Zhang Z, Sun L, Chai N, Tang S, Jin J, Hu H, Nie Y, Wang X, Wu K,
Jin H, Fan D. 2011. MicroRNA-499-5p promotes cellular invasion and
tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
Carcinogenesis 32:1798 –1805. https://doi.org/10.1093/carcin/bgr213.
25. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Pre-
diction of mammalian microRNA targets. Cell 115:787–798. https://doi
.org/10.1016/s0092-8674(03)01018-3.
26. Jones TR, Cole MD. 1987. Rapid cytoplasmic turnover of c-myc mRNA:
requirement of the 3= untranslated sequences. Mol Cell Biol 7:4513–4521.
https://doi.org/10.1128/MCB.7.12.4513.
27. Betel D, Wilson M, Gabow A, Marks DS, Sander C. 2008. The microR-
NA.org resource: targets and expression. Nucleic Acids Res 36:
D149 –D153. https://doi.org/10.1093/nar/gkm995.
28. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P,
Rothballer A, Ascano M, Jr, Jungkamp AC, Munschauer M, Ulrich A,
Wardle GS, Dewell S, Zavolan M, Tuschl T. 2010. Transcriptome-wide
identification of RNA-binding protein and microRNA target sites by
PAR-CLIP. Cell 141:129 –141. https://doi.org/10.1016/j.cell.2010.03.009.
29. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ.
2006. miRBase: microRNA sequences, targets and gene nomencla-
ture. Nucleic Acids Res 34:D140 –D144. https://doi.org/10.1093/nar/
gkj112.
30. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett
SJ, Sonenberg N, Colburn NH. 2003. The transformation suppressor
Pdcd4 is a novel eukaryotic translation initiation factor 4A binding
protein that inhibits translation. Mol Cell Biol 23:26 –37. https://doi.org/
10.1128/MCB.23.1.26-37.2003.
31. Ma G, Zhang H, Dong M, Zheng X, Ozaki I, Matsuhashi S, Guo K. 2013.
Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis
and progression of human digestive tract cancers. Tumour Biol 34:
3879 –3885. https://doi.org/10.1007/s13277-013-0975-9.
32. Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, Cheung AN, Chan KK, Ngan
HY. 2009. Loss of programmed cell death 4 (Pdcd4) associates with the
progression of ovarian cancer. Mol Cancer 8:70. https://doi.org/10.1186/
1476-4598-8-70.
33. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y. 2008.
MicroRNA-21 promotes cell transformation by targeting the pro-
grammed cell death 4 gene. Oncogene 27:4373– 4379. https://doi.org/
10.1038/onc.2008.72.
34. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP.
2007. MicroRNA targeting specificity in mammals: determinants beyond
seed pairing. Mol Cell 27:91–105. https://doi.org/10.1016/j.molcel.2007
.06.017.
35. Chandradoss SD, Schirle NT, Szczepaniak M, MacRae IJ, Joo C. 2015. A
dynamic search process underlies microRNA targeting. Cell 162:96 –107.
https://doi.org/10.1016/j.cell.2015.06.032.
36. Rüegger S, Großhans H. 2012. MicroRNA turnover: when, how, and why.
Trends Biochem Sci 37:436 – 446. https://doi.org/10.1016/j.tibs.2012.07
.002.
37. Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, Lin MT, Chu CY, Hua
KT, Chen CN, Kuo TC, Chang KJ, Hsiao M, Chang YW, Chen JS, Yang PC,
Kuo ML. 2011. miR-107 promotes tumor progression by targeting the
let-7 microRNA in mice and humans. J Clin Invest 121:3442–3455.
https://doi.org/10.1172/JCI45390.
38. Zisoulis DG, Kai ZS, Chang RK, Pasquinelli AE. 2012. Autoregulation of
microRNA biogenesis by let-7 and Argonaute. Nature 486:541–544.
https://doi.org/10.1038/nature11134.
39. Tang R, Li L, Zhu D, Hou D, Cao T, Gu H, Zhang J, Chen J, Zhang CY, Zen
K. 2012. Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogene-
sis at the posttranscriptional level in the nucleus: evidence for a mi-
croRNA hierarchy system. Cell Res 22:504 –515. https://doi.org/10.1038/
cr.2011.137.
40. Yu Y, Nangia-Makker P, Farhana L, Rajendra SG, Levi E, Majumdar AP. 2015.
miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
Mol Cancer 14:98. https://doi.org/10.1186/s12943-015-0372-7.
41. Lai EC, Wiel C, Rubin GM. 2004. Complementary miRNA pairs suggest a
regulatory role for miRNA:miRNA duplexes. RNA 10:171–175. https://doi
.org/10.1261/rna.5191904.
42. Chatterjee S, Fasler M, Büssing I, Großhans H. 2011. Target-mediated
protection of endogenous microRNAs in C. elegans. Dev Cell 20:
388 –396. https://doi.org/10.1016/j.devcel.2011.02.008.
43. Marzi MJ, Ghini F, Cerruti B, de Pretis S, Bonetti P, Giacomelli C, Gorski
MM, Kress T, Pelizzola M, Muller H, Amati B, Nicassio F. 2016. Degrada-
tion dynamics of microRNAs revealed by a novel pulse-chase ap-
proach. Genome Res 26:554 –565. https://doi.org/10.1101/gr.198788
.115.
44. Bose M, Bhattacharyya SN. 2016. Target-dependent biogenesis of cog-
nate microRNAs in human cells. Nat Commun 7:12200. https://doi.org/
10.1038/ncomms12200.
45. Khoury S, Tran N. 2015. Circulating microRNAs: potential biomarkers for
common malignancies. Biomark Med 9:131–151. https://doi.org/10
.2217/bmm.14.102.
46. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R,
Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A,
Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expres-
sion signature of human solid tumors defines cancer gene targets. Proc
Natl Acad Sci U S A 103:2257–2261. https://doi.org/10.1073/pnas
.0510565103.
47. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data
using real-time quantitative PCR and the 2ΔΔCT method. Methods
25:402– 408. https://doi.org/10.1006/meth.2001.1262.
48. Hill AV. 1910. A new mathematical treatment of changes of ionic con-
centration in muscle and nerve under the action of electric currents,
with a theory as to their mode of excitation. J Physiol 40:190 –224.
https://doi.org/10.1113/jphysiol.1910.sp001366.
miRNA-to-miRNA Regulation of PDCD4 Molecular and Cellular Biology
September 2019 Volume 39 Issue 18 e00086-19 mcb.asm.org 15
 on A
pril 20, 2020 at U
N
IV
E
R
S
IT
Y
 O
F
 T
E
C
H
 S
Y
D
N
E
Y
http://m
cb.asm
.org/
D
ow
nloaded from
 
